LivaNova PLC: LivaNova Initiates Targeted Commercial Launch of the Essenz Patient Monitor for Cardiopulmonary Bypass Procedures

Intuitive monitor featuring patient-tailored approach is now in clinical use in select centers in U.S. and Europe LivaNova PLC (NASDAQ: LIVN), a market-leading medical technology and innovation company

Related Keywords

Netherlands ,London ,City Of ,United Kingdom ,Marco Dolci ,Deanna Wilke ,Ed Overdevest ,Corporate Communications ,Drug Administration ,Essenz Patient Monitor ,Essenz Perfusion System ,Clinical Perfusionist ,Catharina Hospital ,Goal Directed Therapy ,Cardiopulmonary Bypass ,Annual Report ,Quarterly Reports ,Current Reports ,Enova Investor Relations ,Media Contacts ,Investor Relations ,Livanova ,Nitiates ,Argeted ,Commercial ,Launch ,Ssenz ,Patient ,Monitor ,Cardiopulmonary ,Bypass ,Procedures ,